Gut bacteria gene may hold key to Parkinson's

NCT ID NCT07175922

Recruiting now Knowledge-focused Sponsor: Vertero Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at a gene called csgA found in gut bacteria of people with Parkinson's disease. Researchers want to see how common this gene is and how it changes over time. The goal is to learn more about the link between gut health and Parkinson's, which could help develop future treatments. The study will involve 200 participants with Parkinson's who have or had gut issues.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could point toward new therapies that target the gut to treat Parkinson's disease.
What could go wrong: This is an observational study, not a treatment trial. It only measures a gene in stool samples, so it won't directly test any therapy. Results may not lead to a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSONS DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSONS DISEASE (PD)

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Center for Human Drug Research
RECRUITING

Leiden, Netherlands

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.